Guard Therapeutics International AB (publ) (STO:GUARD)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.9640
-0.0640 (-6.23%)
Apr 24, 2026, 5:29 PM CET
Market Cap19.44M -93.5%
Revenue (ttm)n/a
Net Income-108.85M
EPS-6.04
Shares Out20.17M
PE Ration/a
Forward PE0.42
Dividendn/a
Ex-Dividend Daten/a
Volume65,703
Average Volume52,090
Open1.0500
Previous Close1.0280
Day's Range0.9500 - 1.0500
52-Week Range0.8810 - 27.0000
Beta-0.06
RSI29.74
Earnings DateMay 7, 2026

About STO:GUARD

Guard Therapeutics International AB (publ), a clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden. The company’s pipeline products include RMC-035, an intact therapeutic A1M protein, that is in Phase 2b clinical trial for kidney protection with open-heart surgery; in Phase 2a clinical trial for kidney transplantation; and is in preclinical trial to treat Sepsis. It also develops GTZ peptides, a modified A1M-derived peptides which is in preclinical studies for the treatment of CKD and diabet... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 12
Stock Exchange Nasdaq Stockholm
Ticker Symbol GUARD
Full Company Profile

Financial Performance

Financial Statements